Alkermes
ALKS
#3093
Rank
HK$37.94 B
Marketcap
HK$229.80
Share price
0.75%
Change (1 day)
-5.32%
Change (1 year)

Alkermes (ALKS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$4.64 Billion

According to Alkermes's latest financial reports the company's total liabilities are HK$4.64 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Alkermes - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$4.58 B-37.11%
2023-12-31HK$7.29 B1.41%
2022-12-31HK$7.18 B1.12%
2021-12-31HK$7.11 B3.91%
2020-12-31HK$6.84 B22.05%
2019-12-31HK$5.60 B9.53%
2018-12-31HK$5.11 B10.23%
2017-12-31HK$4.64 B15.85%
2016-12-31HK$4.00 B-4.48%
2015-12-31HK$4.19 B3.61%
2014-12-31HK$4.05 B
2013-03-31HK$4.02 B-10.93%
2012-03-31HK$4.51 B860.36%
2011-03-31HK$0.47 B-41.23%
2010-03-31HK$0.79 B-21.58%
2009-03-31HK$1.01 B-62.66%
2008-03-31HK$2.73 B-4.27%
2007-03-31HK$2.85 B-17.52%
2006-03-31HK$3.45 B32.54%
2005-03-31HK$2.60 B72.69%
2004-03-31HK$1.51 B-25.69%
2003-03-31HK$2.03 B4.01%
2002-03-31HK$1.95 B3.23%
2001-03-31HK$1.89 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Acorda Therapeutics
ACOR
HK$2.08 B-55.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$609.44 B 13,033.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$883.85 B 18,947.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$900.17 B 19,299.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$533.12 B 11,389.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$253.79 B 5,369.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Sanofi
SNY
HK$513.99 B 10,976.89%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
HK$486.82 B 10,391.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland